- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06107855
Low-dose Maximal-intent Versus Controlled-tempo Resistance Training on Quality-of-life in Adults
October 24, 2023 updated by: Northumbria University
Comparison of Low-dose Maximal-intent Versus Controlled-tempo Resistance Training on Quality-of-life, Functional Capacity, and Strength in Untrained Healthy Adults: a Randomised Controlled Trial
The aims of this study were to:
- Compare the effects of low-dose Maximal Intent and Controlled Tempo Resistance Training on untrained healthy adults' quality-of-life, functional capacity, and strength.
- Qualitatively explore perceptions of Maximal Intent and Controlled Tempo Resistance Training.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tyne And Wear
-
Newcastle, Tyne And Wear, United Kingdom, NE1 8ST
- Nortuhmbria University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Participants were eligible if they were between 30-60 years old
- Uninjured
- Had no cardiovascular or neuromuscular conditions
- Had not participated in lower-limb RT in the previous six months.
Exclusion Criteria:
- Participants were excluded if they had either taken part in any lower-limb RT in the last six months
- Had underlying health condition(s) that prevented them from participating in RT
- Regularly met or exceeded the UK recommended PA guideline of 150-minutes of moderate to intense PA per week.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Maximal-intent Resistance Training
The MI group was instructed and encouraged to deliberately commit to exerting maximal effort and force during the concentric phase of the leg press with the intention of achieving the greatest velocity possible.
|
Participants used said unilateral leg press at 60% one-repetition max for either 3 sets x 5 reps, or 5 sets x 5 reps, at either maximal- or controlled-tempo-intent.
|
|
Experimental: Controlled-tempo Resistance Training
While the CT group followed the metronome for both eccentric and concentric phases.
|
Participants used said unilateral leg press at 60% one-repetition max for either 3 sets x 5 reps, or 5 sets x 5 reps, at either maximal- or controlled-tempo-intent.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality-of-life
Time Frame: The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
Participant quality of life (focus group questions & SF-36)
|
The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Balance
Time Frame: The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
Using the biodex SD to do a 3 x 20s double-foot eyes-open balance test on Level 6.
|
The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
|
6-minute Walk Test (6MWT)
Time Frame: The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
a "brisk"-paced 6-minute walk test.
|
The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
|
Timed-up-and-go (TUG)
Time Frame: The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
Standing from a chair, walking to a point 3 metres away, turn, and return to the chair as quick as possible whilst walking.
|
The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
|
30-second sit-to-stand (30s-STS)
Time Frame: The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
Maximal amount of repetitions a participant can stand up from a chair in 30-seconds.
|
The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
|
Strength (1RM)
Time Frame: The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
Participants one-repetition max on leg press
|
The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
|
BMI
Time Frame: The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
Additional measures calculated from participants test results
|
The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
|
Strength-to-mass
Time Frame: The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
Additional measures calculated from participants test results
|
The time frame for my testing intervals will be conducted at specific time points: at baseline, Week 1, Week 4, and Week 9, out of a total study duration of 9 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gill Barry, PhD, Northumbria University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2022
Primary Completion (Actual)
March 29, 2023
Study Completion (Actual)
March 29, 2023
Study Registration Dates
First Submitted
September 18, 2023
First Submitted That Met QC Criteria
October 24, 2023
First Posted (Actual)
October 30, 2023
Study Record Updates
Last Update Posted (Actual)
October 30, 2023
Last Update Submitted That Met QC Criteria
October 24, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 45459
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway
Clinical Trials on Leg Press Resistance Training Machine
-
Northumbria UniversityCompletedQuality of LifeUnited Kingdom
-
National Taiwan University HospitalUnknown
-
Cairo UniversityActive, not recruitingKnee Osteoarthritis | Blood Flow Restriction TherapyEgypt
-
Karolinska InstitutetCorporacion Parc TauliCompleted
-
Giresun UniversityCompletedResistance Exercise | Muscle Contractile Properties | Foot Progression AngleTurkey (Türkiye)
-
China Medical University HospitalCompleted
-
Nihat SarıalioğluCompletedResistance Training | Muscle Mechanical PropertiesTurkey (Türkiye)
-
University of MichiganCompletedAnterior Cruciate Ligament InjuryUnited States
-
Taipei Veterans General Hospital, TaiwanEnrolling by invitationHyperglycemia | Quality of Life | Diabetic Foot | Wound Healing | Resistance Exercise
-
Kyoto UniversityCompletedElderly | Congestive Heart Failure | Endothelium-derived FactorsJapan